Literature DB >> 22344899

Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.

Sharon W Kwan1, Nicholas Fidelman, Elizabeth Ma, Robert K Kerlan, Francis Y Yao.   

Abstract

Transarterial chemoembolization (TACE) is one of the standard therapies for bridging patients with hepatocellular carcinoma (HCC) to transplantation. This study was designed to determine which features on pre- and post-TACE imaging are associated with tumor necrosis in pathological specimens. Records of 105 patients with 132 HCC lesions who underwent liver transplantation after TACE were retrospectively reviewed. In 70% of the nodules, >90% necrosis was achieved. The development of >90% lesion necrosis upon pathological analysis was associated with avid lesion enhancement (P = 0.03) and the presence of a feeding vessel larger than 0.9 mm in diameter on the pre-TACE visceral angiogram (P = 0.01). Near-complete lesion necrosis was also associated with an extensive accumulation of ethiodized oil within a lesion during TACE administration (P = 0.04). On post-TACE computed tomography imaging, a lack of residual contrast enhancement (P < 0.0001), a decrease in the lesion size (P = 0.04), a high lesion density due to an accumulation of ethiodized oil (P = 0.03), and a diffuse distribution of ethiodized oil throughout the lesion (P = 0.0001) were also correlated with near-complete lesion necrosis upon pathological analysis. In conclusion, this study found multiple pre- and post-TACE imaging characteristics of HCC that were associated with near-complete tumor necrosis upon histopathological analysis after TACE. These findings may help to guide the selection of an optimal treatment strategy for bridging patients with HCC to liver transplantation.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22344899      PMCID: PMC4161220          DOI: 10.1002/lt.23413

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  27 in total

1.  Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation.

Authors:  Matteo Ravaioli; Gian Luca Grazi; Giorgio Ercolani; Michelangelo Fiorentino; Matteo Cescon; Rita Golfieri; Franco Trevisani; Walter Franco Grigioni; Luigi Bolondi; Antonio Daniele Pinna
Journal:  Transplantation       Date:  2004-12-27       Impact factor: 4.939

2.  Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation.

Authors:  Yoshiki Asayama; Kengo Yoshimitsu; Yunosuke Nishihara; Hiroyuki Irie; Shinichi Aishima; Akinobu Taketomi; Hiroshi Honda
Journal:  AJR Am J Roentgenol       Date:  2008-01       Impact factor: 3.959

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.

Authors:  P E Majno; R Adam; H Bismuth; D Castaing; A Ariche; J Krissat; H Perrin; D Azoulay
Journal:  Ann Surg       Date:  1997-12       Impact factor: 12.969

5.  Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.

Authors:  Georgios C Sotiropoulos; M Malago; E P Molmenti; A Radtke; E I Brokalaki; S Nadalin; H Lang; A Frilling; H A Baba; H Kühl; R Verhagen; C E Broelsch
Journal:  Eur J Med Res       Date:  2005-12-07       Impact factor: 2.175

Review 6.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

7.  Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.

Authors:  Jeong Han Kim; Ji Hoon Kim; Jong Hwan Choi; Chung Ho Kim; Young Kul Jung; Hyung Joon Yim; Jong Eun Yeon; Jong-Jae Park; Jae Seon Kim; Young-Tae Bak; Kwan Soo Byun
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

8.  Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.

Authors:  Francis Y Yao; Robert K Kerlan; Ryutaro Hirose; Timothy J Davern; Nathan M Bass; Sandy Feng; Marion Peters; Norah Terrault; Chris E Freise; Nancy L Ascher; John P Roberts
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

9.  Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.

Authors:  T Higuchi; M Kikuchi; M Okazaki
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

10.  Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.

Authors:  S Herber; S Biesterfeld; U Franz; J Schneider; J Thies; M Schuchmann; C Düber; M B Pitton; G Otto
Journal:  Cardiovasc Intervent Radiol       Date:  2008-01-15       Impact factor: 2.740

View more
  48 in total

1.  Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter?

Authors:  Sieh-Yang Lee; Hsin-You Ou; Chun-Yen Yu; Tung-Liang Huang; Leo Leung-Chit Tsang; Yu-Fan Cheng
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

2.  Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Authors:  Min Xu; Mb Majella Doyle; Babak Banan; Neeta Vachharajani; Xuanchuan Wang; Nael Saad; Kathryn Fowler; Elizabeth M Brunt; Yiing Lin; William C Chapman
Journal:  J Am Coll Surg       Date:  2017-04-09       Impact factor: 6.113

3.  Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.

Authors:  Julius Chapiro; Laura D Wood; MingDe Lin; Rafael Duran; Toby Cornish; David Lesage; Vivek Charu; Rüdiger Schernthaner; Zhijun Wang; Vania Tacher; Lynn Jeanette Savic; Ihab R Kamel; Jean-François Geschwind
Journal:  Radiology       Date:  2014-07-15       Impact factor: 11.105

4.  Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival.

Authors:  Dong Ho Lee; Jeong Min Lee; Pyo Nyun Kim; Yun-Jin Jang; Tae Wook Kang; Hyunchul Rhim; Jung Wook Seo; Young Joon Lee
Journal:  Eur Radiol       Date:  2019-02-15       Impact factor: 5.315

5.  Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.

Authors:  A Lam; D Fernando; C C Sirlin; M Nayyar; S C Goodwin; D K Imagawa; C Lall
Journal:  Clin Radiol       Date:  2017-08-02       Impact factor: 2.350

6.  Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.

Authors:  Bruno C Odisio; Aaron Ashton; Yuanqing Yan; Wei Wei; Ahmed Kaseb; Michael J Wallace; Jean N Vauthey; Sanjay Gupta; Alda L Tam
Journal:  J Vasc Interv Radiol       Date:  2015-06-05       Impact factor: 3.464

7.  Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization.

Authors:  Woo Sun Rou; Byung Seok Lee; Hee Seok Moon; Eaum Seok Lee; Seok Hyun Kim; Heon Young Lee
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 8.  Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.

Authors:  Dong-Wei Xu; Ping Wan; Qiang Xia
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 9.  Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.

Authors:  Maurizio Pompili; Giampiero Francica; Francesca Romana Ponziani; Roberto Iezzi; Alfonso Wolfango Avolio
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 10.  Liver transplantation for hepatocellular carcinoma.

Authors:  Jerome Byam; John Renz; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2013-02       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.